LinkedIn
YouTube
Instagram
Contact Us
1-800-850-9132
Log In
#KidneyCancer
@KidneyCancer

YOU MATTER.
WE CARE.
YOU ARE NOT ALONE.

ACCESS INFORMATION & LITERATURE
JOIN NOW
ABOUT DISEASE TREATMENT
GET INFORMATION
SUPPORT RESEARCH
MAKE A DONATION

Upcoming Events

FIND MORE

Publications

NCCN GUIDELINES FOR PATIENTS

Kidney Cancer

DOWNLOAD BOOK
WE HAVE

Kidney Cancer

DOWNLOAD BOOK
VIEW ALL PUBLICATIONS
0
%

5-Year Survival Rate Percentage increase from 2007 through 2013

0

Estimated new cases in the US, this year

0

Estimated Deaths in the US, this year

0

People are living with kidney and renal pelvis cancer, according to NCI SEER data from 2014

Evaluate your treatment options and make decisions

From the Pressroom

Videos: 2017 Kidney Cancer Association Patient & Survivor Conference

Videos from KCA patient and survivor conference that held in North Carolina on December 9th, 2017 is now available online.

Read More

FDA Grants Breakthrough Designation for Avelumab in Combination with INLYTA in Advanced Renal Cell Carcinoma

A combination approach with an immunotherapy, whose activity may complement existing agents such as INLYTA, has the potential to improve outcomes for patients with advanced renal cancer…

Read More

FDA Approves Adjuvant Sunitinib for High-Risk RCC

The FDA has approved sunitinib (Sutent) for use as an adjuvant therapy in patients with renal cell carcinoma (RCC) who have received nephrectomy and are high risk for recurrence.

Read More
More from the Press Room

YOU MATTER.
WE CARE.
YOU ARE NOT ALONE.

DONATE NOW

  Kidney Cancer Association

#190 - Error validating application. Invalid application ID. Here are some possible solutions to fix the error.

  #KidneyCancer

  kidneycancerassociation

4 days ago
  • 14
  • 0
1 week ago
  • 13
  • 0
1 week ago
  • 20
  • 1

  Kidney Cancer

Menu